| 11 | 1/1 | 返回列表 |
| 查看: 841 | 回復(fù): 10 | |||
[交流]
邀稿 (糖尿病足相關(guān))(Frontiers in Pharmacology,中科院二區(qū)top )
|
|||
|
最近受邀搞一個(gè)特刊,有關(guān)于糖尿病足,具體內(nèi)容如下: 期刊名:Frontiers in Pharmacology (中科院分區(qū):二區(qū)top) 切記:OA期刊 (文章接受后需要交版面費(fèi)) 內(nèi)容:與糖尿病足相關(guān)(研究,綜述,臨床研究報(bào)告等均可) 歡迎大家來(lái)搞。 Diabetes is a complex metabolic disease that affects more than 340 million individuals worldwide. Around 20% of these patients develop diabetic wounds. Diabetic foot ulcers (DFUs) are a common complication of diabetes that are recalcitrant to healing due to persistent inflammation. Only one FDA-approved medicine, becaplermin, is used to treat DFUs, but it is not the first-line therapy because of its low efficacy and higher risk of cancer and mortality. The absence of effective and safe treatment has necessitated the development of more effective medications or procedures. The mechanism underlying this process, however, remains unknown, prompting further research into diabetic foot ulcer etiology. The development of diabetic wounds is a serious complication for patients with diabetes. Peripheral neuropathy, foot deformity, external trauma, peripheral vascular disease, and peripheral oedema are just a few of the contributing elements that lead to foot ulcers in diabetic individuals. Infection is widespread in DFUs, resulting in the patient’s protracted hospitalization and psychological issues. A better understanding of pathogenic variables can aid in the development of innovative treatments for poor healing. The aim of this Research Topic is to provide a forum focusing on the pathogenesis of DFUs. An understanding of the critical pathways involved will guide future therapies against DFUs. Studies investigating contributing factors of diabetic foot in vitro and in vivo, as well as human clinical samples, are encouraged to accelerate the development of innovative therapies and drugs. Manuscripts relating to DFUs focusing on, but are not limited to, the following topics are invited in this Research Topic: • Identification of new biological pathways and mechanisms • Clinical data sets • Therapeutic regimens for the management of DFUs |
» 搶金幣啦!回帖就可以得到:
+1/186
+1/88
+1/87
+1/78
+1/34
+1/34
+1/33
+1/33
+1/31
+1/8
+1/8
+1/5
+1/5
+1/4
+1/4
+1/3
+1/2
+1/2
+1/2
+1/2
木蟲(chóng)之王 (文學(xué)泰斗)
| 11 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 080500材料科學(xué)與工程 +5 | 202114020319 2026-03-03 | 5/250 |
|
|---|---|---|---|---|
|
[考研]
材料325求調(diào)劑
30+5
|
mariusuki 2026-03-02 | 10/500 |
|
|
[考研] 中國(guó)科學(xué)技術(shù)大學(xué)材料與化工281求調(diào)劑,有科研和獲獎(jiǎng)經(jīng)歷 +7 | wsxw 2026-03-02 | 8/400 |
|
|
[考研]
085600 英一數(shù)二272求調(diào)劑
5+6
|
vida_a 2026-03-01 | 45/2250 |
|
|
[考研] 347求調(diào)劑 +3 | 啊歐歐歐 2026-03-03 | 3/150 |
|
|
[考研] 266求調(diào)劑 +5 | 哇塞王帥 2026-03-03 | 5/250 |
|
|
[考研] 中國(guó)林科院林化所(南京)2026年招收化學(xué)/材料/環(huán)境工程等背景碩士研究生3名 +3 | realstar2006 2026-02-27 | 3/150 |
|
|
[考研] 一志愿東北大學(xué)化學(xué)314分求調(diào)劑 +5 | lr1212.. 2026-03-02 | 5/250 |
|
|
[考研] 化工270求調(diào)劑 +10 | 什么名字qwq 2026-03-02 | 10/500 |
|
|
[考研] 290分材料工程085601求調(diào)劑 數(shù)二英一 +8 | llx0610 2026-03-02 | 9/450 |
|
|
[考研] 求調(diào)劑 +7 | repeatt?t 2026-02-28 | 7/350 |
|
|
[考研] 0856材料調(diào)劑 +5 | 沿岸有貝殼OUC 2026-03-02 | 5/250 |
|
|
[考研] 材料工程274求調(diào)劑 +5 | Lilithan 2026-03-01 | 5/250 |
|
|
[考研] 化工專碩342,一志愿大連理工大學(xué),求調(diào)劑 +6 | kyf化工 2026-02-28 | 7/350 |
|
|
[考研] 材料調(diào)劑 +6 | 愛(ài)擦汗的可樂(lè)冰 2026-02-28 | 7/350 |
|
|
[考研] 調(diào)劑 +3 | 13853210211 2026-03-02 | 4/200 |
|
|
[考研] 291分工科求調(diào)劑 +9 | science餓餓 2026-03-01 | 10/500 |
|
|
[考研] 0856材料求調(diào)劑 +4 | 麻辣魷魚(yú) 2026-02-28 | 4/200 |
|
|
[考研] 調(diào)劑 +3 | 簡(jiǎn)木ChuFront 2026-02-28 | 3/150 |
|
|
[考研]
|
LYidhsjabdj 2026-02-28 | 4/200 |
|